ConductScience.org, home

Paper33568554

Understanding the Impact of Resistance to Influenza Antivirals.

Holmes EC and 5 others. Clin Microbiol Rev, 2021. Cited by 64 papers, by iCite.

Cite this record

ConductScience Library. Understanding the Impact of Resistance to Influenza Antivirals. Papers, record 33568554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33568554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Understanding the Impact of Resistance to Influenza Antivirals.
PubMed
Journal
Clin Microbiol Rev
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
64
iCite
Relative citation ratio, by iCite
3.89
iCite
Revised in PubMed
2022-02-11
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Holmes ECEdward Chttps://orcid.org/0000-0001-9596-3552
2Hurt ACAeron C
3Dobbie ZZuzana
4Clinch BBarry
5Oxford JSJohn S
6Piedra PAPedro A

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
Influenza, HumanMajor topic
Drug Resistance, Viral
Humans

References79

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123732307Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial.J Infect Chemother2013https://conductscience.org/library/papers/23732307PubMed
21576586Antiviral therapy: current concepts and practices.Clin Microbiol Rev1992https://conductscience.org/library/papers/1576586PubMed
320936975Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial.Clin Infect Dis2010https://conductscience.org/library/papers/20936975PubMed
432056049Influenza and antiviral resistance: an overview.Eur J Clin Microbiol Infect Dis2020https://conductscience.org/library/papers/32056049PubMed
532071422We shouldn't worry when a virus mutates during disease outbreaks.Nat Microbiol2020https://conductscience.org/library/papers/32071422PubMed
619048205Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.Handb Exp Pharmacol2009https://conductscience.org/library/papers/19048205PubMed
730184455Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.N Engl J Med2018https://conductscience.org/library/papers/30184455PubMed
823437766Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus.J Med Chem2013https://conductscience.org/library/papers/23437766PubMed
925691635Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/25691635PubMed
1030086337Comparison of antiviral resistance across acute and chronic viral infections.Antiviral Res2018https://conductscience.org/library/papers/30086337PubMed
1120215135Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations.J Antimicrob Chemother2010https://conductscience.org/library/papers/20215135PubMed
1219812437Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.Antivir Ther2009https://conductscience.org/library/papers/19812437PubMed
1320368393Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20368393PubMed
1427178527Antibiotic-Induced Changes in the Intestinal Microbiota and Disease.Trends Mol Med2016https://conductscience.org/library/papers/27178527PubMed
1529265727Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study.Influenza Other Respir Viruses2018https://conductscience.org/library/papers/29265727PubMed
1631538644Baloxavir Marboxil in Japanese Pediatric Patients With Influenza: Safety and Clinical and Virologic Outcomes.Clin Infect Dis2020https://conductscience.org/library/papers/31538644PubMed
1727281742Approved Antiviral Drugs over the Past 50 Years.Clin Microbiol Rev2016https://conductscience.org/library/papers/27281742PubMed
1828694997Antiviral drug resistance as an adaptive process.Virus Evol2016https://conductscience.org/library/papers/28694997PubMed
1922966122Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmission.J Infect Dis2012https://conductscience.org/library/papers/22966122PubMed
2029941893Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil.Sci Rep2018https://conductscience.org/library/papers/29941893PubMed

See all 79 referencesDownload CSV of references

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.

PMIDTitleJournalYearIn PapersSource
42947434Efficacy and safety of Lianhua Qingwen versus oseltamivir in children with influenza: a multicenter, randomized, double-blind, positive parallel-controlled study.Pharm Biol2026https://conductscience.org/library/papers/42947434PubMed
42851010Trends, Gaps, and Challenges in Antiviral Resistance: A Bibliometric Analysis and Narrative Synthesis of Key Viruses, Resistance Mechanisms, and Drivers.Biomed Res Int2026https://conductscience.org/library/papers/42851010PubMed
42617142A bispecific antibody targeting conserved hemagglutinin epitopes confers broad protection against H7 avian influenza and accelerates viral clearance via localized respiratory delivery.Emerg Microbes Infect2026https://conductscience.org/library/papers/42617142PubMed
42560041Detection and characterization of antiviral-resistant viruses during the influenza season of 2024-25.Microbiol Spectr2026https://conductscience.org/library/papers/42560041PubMed
42306964Antiviral Resistance in Influenza: Clinical and Public Health Implications.Influenza Other Respir Viruses2026https://conductscience.org/library/papers/42306964PubMed
42262426IgY technology (egg yolk antibodies) in respiratory medicine: applications and future prospects.Arch Microbiol2026https://conductscience.org/library/papers/42262426PubMed
42164493Research progress in the inhibitory mechanisms of traditional Chinese medicine therapies against influenza A.Front Immunol2026https://conductscience.org/library/papers/42164493PubMed
42099460A large-scale single-cell transcriptomic atlas indicates the immune panorama of influenza A infection.Imeta2026https://conductscience.org/library/papers/42099460PubMed
41751469Rhus coriaria Linn Extract as a Natural Inhibitor of Influenza A Virus Replication In Vitro.Curr Issues Mol Biol2026https://conductscience.org/library/papers/41751469PubMed
41594075Leveraging Different Distance Functions to Predict Antiviral Peptides with Geometric Deep Learning from ESMFold-Predicted Tertiary Structures.Antibiotics (Basel)2026https://conductscience.org/library/papers/41594075PubMed
41555529Emergence of the novel PA-D27G mutation conferring reduced baloxavir susceptibility in influenza A viruses circulating in China, 2018-2025.Emerg Microbes Infect2026https://conductscience.org/library/papers/41555529PubMed
41105303Antiviral strategies against H5N1: current options and emerging therapeutics.Infection2026https://conductscience.org/library/papers/41105303PubMed
41025086Recent advances in avian influenza virus: Molecular pathogenesis, emerging strains, and next-generation therapeutics.World J Virol2025https://conductscience.org/library/papers/41025086PubMed
40929256Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations.Sci Adv2025https://conductscience.org/library/papers/40929256PubMed
40883700Epidemiological dynamics of influenza B virus across multiple seasons in Kenya and Uganda inferred from sequence data, 2010-2021.BMC Infect Dis2025https://conductscience.org/library/papers/40883700PubMed
40378143Fast and flu-rious: How to prevent and treat emerging influenza A viruses.PLoS Pathog2025https://conductscience.org/library/papers/40378143PubMed
40176109Neutralizing monoclonal antibodies as effective therapeutics and prophylactics against lethal H10N7 avian influenza infection in a mouse model.Vet Res2025https://conductscience.org/library/papers/40176109PubMed
40146495Identification of Novel Neuraminidase Inhibitors as Potential Anti-Influenza Agents: Virtual Screening, Molecular Docking, in vitro Validation and Molecular Dynamic Simulation Studies.Cell Biochem Biophys2025https://conductscience.org/library/papers/40146495PubMed
39717708A meta-analysis highlights the idiosyncratic nature of tradeoffs in laboratory models of virus evolution.Virus Evol2024https://conductscience.org/library/papers/39717708PubMed
39458339Interplay between Lung Diseases and Viral Infections: A Comprehensive Review.Microorganisms2024https://conductscience.org/library/papers/39458339PubMed

See all 45 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33568554

GET https://conductscience.org/api/papers/v1/33568554/references?page=2